Patient Selection for Neoadjuvant Therapy in Early-Stage Pancreatic Cancer
J Clin Oncol
.
2017 May 10;35(14):1622-1623.
doi: 10.1200/JCO.2016.71.2315.
Epub 2017 Jan 30.
Authors
John R Bergquist
1
,
Christopher R Shubert
1
,
Curtis B Storlie
1
,
Elizabeth B Habermann
1
,
Mark J Truty
1
Affiliation
1
John R. Bergquist, Christopher R. Shubert, Curtis B. Storlie, Elizabeth B. Habermann, and Mark J. Truty, Mayo Clinic, Rochester, MN.
PMID:
28135141
DOI:
10.1200/JCO.2016.71.2315
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Neoadjuvant Therapy*
Pancreas
Pancreatic Neoplasms*
Patient Selection
Propensity Score